Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease1

Abstract

We conclude that high viral load is systematic in patients who underwent primary EBV infection and is indicative of the PTLD risk only if there is low concomitant cellular immune response. Healing from PTLD requires modulation of immunosuppression, and appearance of EBV-TL.

References

Page 1

	Year	Citations
REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY Thomas E. Starzl, K. A. Porter, Shunzaburo Iwatsuki, The Lancet Lymphoid NeoplasiaSurgical PathologyPathologyLymphatic DiseaseDermatology	1984	1.3K
PREVENTION AND PREEMPTIVE THERAPY OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER RECIPIENTS1 Sue V. McDiarmid, Stan Jordan, Geoffrey S. Lee, Transplantation	1998	343
Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease A Savoie, C Perpete, L. Carpentier, Blood	1994	274
PATIENTS AT RISK FOR DEVELOPMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER: PLASMA VERSUS PERIPHERAL BLOOD MONONUCLEAR CELLS AS MATERIAL FOR QUANTIFICATION OF EPSTEIN-BARR VIRAL LOAD BY USING REAL-TIME QUANTITATIVE POLYMERASE CHAIN REACTION1,2 Hans-Joachim Wagner, Meike Wessel, Wolfram J. Jabs, Transplantation	2001	216
Early Signs And Risk Factors For The Increased Incidence Of Epstein-Barr Virus-Related Posttransplant Lymphoproliferative Diseases In Pediatric Liver Transplant Recipients Treated With Tacrolimus Étienne Sokal, Henedina Antunes, Claire Beguin, Transplantation	1997	185
High Levels of Epstein-Barr Virus DNA in Blood of Solid-Organ Transplant Recipients and Their Value in Predicting Posttransplant Lymphoproliferative Disorders Fausto Baldanti, Paolo Grossi, Milena Furione, Journal of Clinical Microbiology	2000	182
SERIAL MEASUREMENT OF EPSTEIN-BARR VIRAL LOAD IN PERIPHERAL BLOOD IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS DURING TREATMENT FOR POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE1 Michael D. Green, Thomas V. Cacciarelli, George Mazariegos, Transplantation	1998	182
Characterization of Epstein-Barr virus–infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response Jie Yang, Qian Tao, Ian W. Flinn, Blood	2000	179
Pediatric liver transplantation with cadaveric or living related donors: Comparative results in 90 elective recipients of primary grafts Raymond Reding, Jean de Ville de Goyet, Isabelle Delbeke, The Journal of Pediatrics Transplant RejectionComparative ResultsOrgan DonationTransplantationHepatology	1999	158
CD8+ T-cell selection, function, and death in the primary immune response in vivo Margaret Callan, Chrysoula Fazou, Hongbing Yang, Journal of Clinical Investigation	2000	157

Page 1